[Discontinuation of immunosuppressive and immunomodulatory drugs in connective tissue diseases]
Abstract
Remission in connective tissue diseases became a realistic goal of therapy nowadays. However, there is lack of recommendations on the management after achieving a remission. Chronic exposure to immunosuppressive or immunomodulatory drugs may be associated with adverse events, that is why temporal wi …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
English Abstract
Bozena Targońska-Stepniak
pmid:26753211
Connective Tissue Diseases / drug therapy*
Drug Administration Schedule
Immunomodulation*
Immunosuppressive Agents / administration & dosage*
Immunosuppressive Agents / adverse effects
Recurrence
Remission Induction
Withholding Treatment*
Access
Citation
ID:
110968
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
110968
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet